Biotalys

“During my time at Biotalys it became apparent how important cost of goods are, and how 'expensive' liquid fermentation actually is. A couple of years later I saw an opportunity to develop an alternative way of cultivating micro-organisms”

“He explained that this is part of the innovation process and that 'If investors can't handle these types of failure, they shouldn't invest in Biotech.' The implication: biotech investors who demand low-variance outcomes are misallocating capital.”